Infinium Global Research Ophthalmic Drugs Market | Page 3
Ophthalmic Drugs Market: Trends and Forecast -2023
include absence of health insurance in developing countries regarding eye diseases
and lack of awareness among the people regarding eye diseases and disorders in
underdeveloped and developing countries. One of the key opportunities for new
entrants is securing drugs through a licensing agreement with major players such as
novartis and bayer, which could boost their growth over the forecast period.
Segment Covered
The report on global ophthalmic drugs market covers segments such as, disease
condition and dispenses type. On the basis of disease condition the global
ophthalmic drugs market is categorized into allergy, glaucoma, dry eye disorder and
retinal disorder. On the basis of dispense type the global ophthalmic drugs market
is categorized into prescription and over the counter.
Geographic Coverage
The report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and
market size for each geography is provided over the period of 2015-2023. The
countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are
included in the European region. The U.S. drives the growth in the North America
region as it is the largest market in the region. The Asia-pacific region offers a
substantial potential for the market growth owing to rapid growth in markets such
as India and China. The APAC region is projected to experience a growth at a CAGR
of x.x% over the period of 2017-2023.
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global ophthalmic drugs
market such as, Abbott Healthcare, Allergan Plc, Johnson & Johnson, Bayer, Valeant
Pharmaceuticals, Inc., Pfizer, Inc., Merck & Co., Novartis AG, Renegeron and Santen
Pharmaceuticals Company Ltd.
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro
and macro indicators. In addition, this report provides insights on the factors that
3
© Infinium Global Research